ImageneBio, Inc. — Director's Dealing 2021

Mar 30, 2021

SEC Form 3/A — Form 3/A

Issuer: Ikena Oncology, Inc. (IKNA)
CIK: 0001835579
Period of Report: 2021-03-25

Reporting Person: Santillana Sergio L. (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.51	2030-07-22	Common Stock (157711)		Direct

Footnotes

F1: 25% of this option shall vest and become exercisable on July 1, 2021, with the remainder vesting in 36 substantially equal monthly installments thereafter.

F2: Due to an administrative error, the Form 3 filed by the Reporting Person on March 25, 2021 (the "Original Form 3") included an incorrect amount of underlying securities in the first row of Table II, Column 3 (1,128,862). This Form 3/A amends the Original Form 3 to correct this error, and does not impact any other holdings reported on the Original Form 3.